Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
57,417,494
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
45,933,803
-
Shares change
-
+1,596,943
-
Total reported value, excl. options
-
$2,235,023,234
-
Value change
-
+$79,981,090
-
Number of buys
-
108
-
Number of sells
-
-47
-
Price
-
$48.65
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) as of Q1 2022
178 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share as of Q1 2022.
Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45,933,803 shares
of 57,417,494 outstanding shares and own 80% of the company stock.
Largest 10 shareholders include Valor Management LLC (11,218,033 shares), FMR LLC (4,897,182 shares), Vivo Capital, LLC (4,570,148 shares), BlackRock Inc. (3,832,919 shares), VANGUARD GROUP INC (2,702,513 shares), JANUS HENDERSON GROUP PLC (1,604,909 shares), venBio Partners LLC (1,544,484 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,132,216 shares), Blackstone Inc. (1,048,951 shares), and STATE STREET CORP (828,181 shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.